These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38940753)

  • 1. The Association between Lymphocytic Thyroiditis and Papillary Thyroid Cancer Harboring Mutant
    Perampalam S; Wu K; Gild M; Tacon L; Bullock M; Clifton-Bligh R
    Thyroid; 2024 Sep; 34(9):1082-1093. PubMed ID: 38940753
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevalence and Impact of BRAF mutation in patients with concomitant papillary thyroid carcinoma and Hashimoto's thyroiditis: a systematic review with meta-analysis.
    Janicki L; Patel A; Jendrzejewski J; Hellmann A
    Front Endocrinol (Lausanne); 2023; 14():1273498. PubMed ID: 38047109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between diffuse lymphocytic infiltration and papillary thyroid cancer aggressiveness according to the presence of thyroid peroxidase antibody and BRAF
    Lee YK; Park KH; Park SH; Kim KJ; Shin DY; Nam KH; Chung WY; Lee EJ
    Head Neck; 2018 Oct; 40(10):2271-2279. PubMed ID: 29935011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic lymphocytic thyroiditis and BRAF V600E in papillary thyroid carcinoma.
    Kim SK; Woo JW; Lee JH; Park I; Choe JH; Kim JH; Kim JS
    Endocr Relat Cancer; 2016 Jan; 23(1):27-34. PubMed ID: 26598713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation Between the Clinicopathological Features of Papillary Thyroid Carcinoma Complicated with Hashimoto's Thyroiditis, BRAF V600E Gene Mutation, and RET Gene Rearrangement.
    Xie M; Xu ZX; Dai M; Zhu YY
    J Coll Physicians Surg Pak; 2024 Apr; 34(4):445-450. PubMed ID: 38576288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRAF mutation in papillary thyroid cancer and its value in tailoring initial treatment: a systematic review and meta-analysis.
    Tufano RP; Teixeira GV; Bishop J; Carson KA; Xing M
    Medicine (Baltimore); 2012 Sep; 91(5):274-286. PubMed ID: 22932786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined effect of Hashimoto's thyroiditis and BRAF(V600E) mutation status on aggressiveness in papillary thyroid cancer.
    Kim SJ; Myong JP; Jee HG; Chai YJ; Choi JY; Min HS; Lee KE; Youn YK
    Head Neck; 2016 Jan; 38(1):95-101. PubMed ID: 25213729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comprehensive prediction model for central lymph node metastasis in papillary thyroid carcinoma with Hashimoto's thyroiditis: BRAF may not be a valuable predictor.
    Chen Y; Zhao S; Zhang Z; Chen Z; Jiang B; An M; Shang M; Wu X; Zhang X; Chen B
    Front Endocrinol (Lausanne); 2024; 15():1429382. PubMed ID: 39363900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-Analyses of Association Between BRAF(V600E) Mutation and Clinicopathological Features of Papillary Thyroid Carcinoma.
    Zhang Q; Liu SZ; Zhang Q; Guan YX; Chen QJ; Zhu QY
    Cell Physiol Biochem; 2016; 38(2):763-76. PubMed ID: 26871894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does papillary thyroid carcinoma have a better prognosis with or without Hashimoto thyroiditis?
    Kwak HY; Chae BJ; Eom YH; Hong YR; Seo JB; Lee SH; Song BJ; Jung SS; Bae JS
    Int J Clin Oncol; 2015 Jun; 20(3):463-73. PubMed ID: 25312294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between BRAF (V600E) mutation and pathological features in PTC.
    Liu X; Yan K; Lin X; Zhao L; An W; Wang C; Liu X
    Eur Arch Otorhinolaryngol; 2014 Nov; 271(11):3041-52. PubMed ID: 24389984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The BRAF V600E Mutation and Clinicopathological Changes Among Patients With Hashimoto Thyroiditis, Papillary Thyroid Carcinoma With Hashimoto Thyroiditis, and Nodular Goiter.
    Deng J; Yu L; Luo S; Yang Z; Liu J; Liao L
    Appl Immunohistochem Mol Morphol; 2024 Aug; 32(7):345-349. PubMed ID: 38775148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk and Prognostic Factors for BRAF
    Wei X; Wang X; Xiong J; Li C; Liao Y; Zhu Y; Mao J
    Biomed Res Int; 2022; 2022():9959649. PubMed ID: 35647194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between BRAF (V600E) mutation and clinicopathological features of papillary thyroid carcinoma: a Brazilian single-centre case series.
    Pessôa-Pereira D; Medeiros MFDS; Lima VMS; Silva JCD; Cerqueira TLO; Silva ICD; Fonseca LE; Sampaio LJL; Lima CRA; Ramos HE
    Arch Endocrinol Metab; 2019; 63(2):97-106. PubMed ID: 30916170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRAF mutation positive papillary thyroid carcinoma is less advanced when Hashimoto's thyroiditis lymphocytic infiltration is present.
    Marotta V; Guerra A; Zatelli MC; Uberti ED; Di Stasi V; Faggiano A; Colao A; Vitale M
    Clin Endocrinol (Oxf); 2013 Nov; 79(5):733-8. PubMed ID: 23469895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRAF V600E Confers Male Sex Disease-Specific Mortality Risk in Patients With Papillary Thyroid Cancer.
    Wang F; Zhao S; Shen X; Zhu G; Liu R; Viola D; Elisei R; Puxeddu E; Fugazzola L; Colombo C; Jarzab B; Czarniecka A; Lam AK; Mian C; Vianello F; Yip L; Riesco-Eizaguirre G; Santisteban P; O'Neill CJ; Sywak MS; Clifton-Bligh R; Bendlova B; Sýkorová V; Wang Y; Xing M
    J Clin Oncol; 2018 Sep; 36(27):2787-2795. PubMed ID: 30070937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association of the BRAF(V600E) mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer: a meta-analysis.
    Kim TH; Park YJ; Lim JA; Ahn HY; Lee EK; Lee YJ; Kim KW; Hahn SK; Youn YK; Kim KH; Cho BY; Park DJ
    Cancer; 2012 Apr; 118(7):1764-73. PubMed ID: 21882184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRAF V600E mutation and its association with clinicopathological features of papillary thyroid cancer: a meta-analysis.
    Li C; Lee KC; Schneider EB; Zeiger MA
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4559-70. PubMed ID: 23055546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Coexistent BRAF
    Moon S; Song YS; Kim YA; Lim JA; Cho SW; Moon JH; Hahn S; Park DJ; Park YJ
    Thyroid; 2017 May; 27(5):651-660. PubMed ID: 28181854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between BRAF V600E Mutation and Ultrasound Features in Papillary Thyroid Carcinoma Patients with and without Hashimoto's Thyroiditis.
    Zhang Q; Liu BJ; Ren WW; He YP; Li XL; Zhao CK; Zhang YF; Yue WW; Zheng JY; Xu HX
    Sci Rep; 2017 Jul; 7(1):4899. PubMed ID: 28687736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.